This Experimental Drug Could Be a Game Changer for Pancreatic Cancer

By
gizmodo.com
-

This Experimental Drug Could Be a Game Changer for Pancreatic Cancer

In a Phase III trial, Revolution Medicines’ daraxonrasib almost doubled the survival length of people with advanced pancreatic cancer.

read more

Source: www.gizmodo.com

RELATED ARTICLES